Cytoplasmic FBXO38 mediates PD-1 degradation

被引：1

作者：

Liu, Xiwei ^{[1
]}

Meng, Xiangbo ^{[2
]}

Lin, Zuomiao ^{[3
]}

Jiang, Shutan ^{[1
]}

Liu, Haifeng ^{[1
]}

Sun, Shao-cong ^{[4
]}

Liu, Xiaolong ^{[1
]}

Zhou, Penghui ^{[5
]}

Huang, Xiaowu ^{[6
,7
,8
]}

Wei, Lai ^{[9
]}

Yang, Wei ^{[10
,11
]}

Xu, Chenqi ^{[1
,3
]}

机构：

[1] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, Shanghai, Peoples R China

[2] Shandong Univ, Adv Med Res Inst, Cheeloo Coll Med, Meili Lake Translat Res Pk, Jinan, Shandong, Peoples R China

[3] Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Sch Life Sci, Hangzhou, Peoples R China

[4] Chinese Inst Med Res, Inst Immunol, Beijing, Peoples R China

[5] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Peoples R China

[6] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Dept Liver Surg & Transplantat, Shanghai 200032, Peoples R China

[7] Fudan Univ, Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai 200032, Peoples R China

[8] Fudan Univ, Zhongshan Hosp, Shanghai Key Lab Organ Transplantat, Shanghai 200032, Peoples R China

[9] Guangzhou Med Univ, Affiliated Hosp 2, Guangdong Prov Key Lab Allergy & Clin Immunol, Guangzhou 510000, Peoples R China

[10] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangdong Prov Key Lab Mol Oncol Pathol, Guangzhou, Peoples R China

[11] Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou, Peoples R China

来源：

EMBO REPORTS | 2024年 / 25卷 / 10期

关键词：

MOKA;

D O I：

10.1038/s44319-024-00254-y

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Comment on “FBXO38 is dispensable for PD-1 regulation” by Dibus et al,

引用

页码：4168 / 4171

页数：4

共 50 条

[41] Alternative splicing of PBRM1 mediates resistance to PD-1 blockade therapy in renal cancer
Cho, Namjoon
Kim, Seung-Yeon
Lee, Sung-Gwon
Park, Chungoo
Choi, Sunkyung
Kim, Eun-Mi
Kim, Kee K.
EMBO JOURNAL, 2024, : 5421 - 5444
[42] PD-1/PD-L1 inhibitors
Sunshine, Joel
Taube, Janis M.
CURRENT OPINION IN PHARMACOLOGY, 2015, 23 : 32 - 38
[43] PD-1/PD-L1 in disease
Kuol, Nyanbol
Stojanovska, Lily
Nurgali, Kulmira
Apostolopoulos, Vasso
IMMUNOTHERAPY, 2018, 10 (02) : 149 - 161
[44] PD-1 interaction with PD-L1 but not PD-L2 on B cells mediates protective effects of estrogen against EAE
Bodhankar, Sheetal
Offner, Halina
JOURNAL OF IMMUNOLOGY, 2013, 190
[45] PD-1 expression by canine T cells and functional effects of PD-1 blockade
Coy, J.
Caldwell, A.
Chow, L.
Guth, A.
Dow, S.
VETERINARY AND COMPARATIVE ONCOLOGY, 2017, 15 (04) : 1487 - 1502
[46] IS THERE A ROLE FOR INCREASED PD-1 AND PD-1 LIGAND EXPRESSIONS AFTER SEPTIC SHOCK?
Guignant, Caroline
Venet, Fabienne
Lepape, Alain
Monneret, Guillaume
SHOCK, 2009, 32 : 20 - 20
[47] PD-L1/PD-1 presence in the tumor microenvironment and activity of PD-1 blockade in multiple myeloma
B Paiva
A Azpilikueta
N Puig
E M Ocio
R Sharma
B O Oyajobi
S Labiano
L San-Segundo
A Rodriguez
I Aires-Mejia
I Rodriguez
F Escalante
A G de Coca
A Barez
J F San Miguel
I Melero
Leukemia, 2015, 29 : 2110 - 2113
[48] Divergent Expression of PD-1 as Challenges and Chances of Immunotherapy Targeting PD-1 or PD-L1 in Cancer
Huang, Haozhe
BIOINFORMATICS AND BIOMEDICAL ENGINEERING, PT II, IWBBIO 2024, 2024, 14849 : 55 - 69
[49] 0.1% Nano-silver mediates PD-1/PD-L1 pathway and alleviates chronic apical periodontitis in rats
Xinxin Sun
Boqi Li
Dilinuer Abula
Liping Wang
Bangyao Wang
Qi Wang
Tao Liu
Ruihan Zhang
Li Sheng
Yinghao Jing
Bei Zhang
Yishan Liu
Odontology, 2023, 111 : 154 - 164
[50] PD-1/PD-L1 Pathway Mediates the Alleviation of Pulmonary Fibrosis by Human Mesenchymal Stem Cells in Humanized Mice
Ni, Ke
Liu, Ming
Zheng, Jian
Wen, Liyan
Chen, Qingyun
Xiang, Zheng
Lam, Kowk-Tai
Liu, Yinping
Chan, Godfrey Chi-Fung
Lau, Yu-Lung
Tu, Wenwei
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2018, 58 (06) : 684 - 695

← 1 2 3 4 5 →